A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis.

"Declarations Ethics approval and consent to participateAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Documented approval for this study was obtained from the Ethics committees of Hasselt University and Jessa Hospital [18.106/infect18.03 and 19.51/infect.19.02]. Written informed consent was obtained from all participants. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study is part of the FAPIC project and has received funding from the European Union’s Horizon 2020 research and innovation program under GA 634137."

"This study was part of a prospective observational cohort study performed between February 2019 and April 2020 at a 981-bed teaching hospital (clinicaltrial.gov identifier NCT03841162)."